The Evolution: From Private Diagnostic Labs to Public Arenas For years, the longevity narrative belonged almost exclusively to clinical diagnostics, pharmaceutical interventions, and quiet metabolic retreats. Millions were poured into measuring VO_2 max, muscle mass retention, and baseline cardiovascular health inside private labs. Then came Hyrox—and brought the diagnostics out of the clinic and into the arena.

The border between community endurance and ultra-luxury portfolios has officially dissolved. LVMH Capital, operating through its premier consumer-focused private equity vehicle L Catterton, has entered advanced exclusive negotiations to acquire a dominant majority stake in the global fitness racing phenomenon, HYROX. The deal, which negotiates terms with Switzerland-based sports marketing and rights giant Infront Sports & Media AG, commands a striking market valuation floor b